Valuation: RAMM Pharma Corp.

Market Cap 597K 425K 372K 344K 315K 40.97M 607K 4.1M 1.61M 20.01M 1.6M 1.56M 69.08M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value -127K -90.14K -78.79K -72.86K -66.86K -8.69M -129K -869K -341K -4.24M -338K -331K -14.64M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 01/10/2019
Director of Finance/CFO - 09/12/2022
Director TitleAgeSince
Director/Board Member - 01/10/2019
Director/Board Member 82 01/10/2019
Director/Board Member 66 01/10/2019
Change 5-day change 1-year change 3-year change Capi.($)
-76.29%-92.33% - - 425K
+1.39%-3.78%+48.26%+161.87% 1,031B
+0.74%-4.26%+50.53%+55.94% 595B
+3.13%+0.69%+32.04%+86.63% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+1.03%-0.84%+29.58%+45.15% 277B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.87%+1.23%+23.11%+61.57% 193B
+2.23%-0.36%+22.30%+73.40% 164B
Average -6.30%-3.79%+25.97%+54.96% 389.37B
Weighted average by Cap. +1.41%-4.31%+34.25%+79.79%

Financials

2024 2025
Net sales 4.34M 3.09M 2.7M 2.5M 2.29M 298M 4.42M 29.82M 11.71M 146M 11.61M 11.36M 502M 3.36M 2.39M 2.09M 1.94M 1.78M 231M 3.42M 23.08M 9.07M 113M 8.99M 8.79M 389M
Net income -16.5M -11.75M -10.27M -9.5M -8.72M -1.13B -16.79M -113M -44.52M -553M -44.14M -43.17M -1.91B -8.91M -6.35M -5.55M -5.13M -4.71M -612M -9.06M -61.18M -24.04M -299M -23.83M -23.31M -1.03B
Net Debt -626K -446K -390K -360K -331K -42.95M -637K -4.3M -1.69M -20.97M -1.67M -1.64M -72.41M -723K -515K -450K -417K -382K -49.66M -736K -4.97M -1.95M -24.25M -1.94M -1.89M -83.72M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-